{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:08:08Z","timestamp":1788782888553,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018916","name":"Suzhou Municipal Health Commission","doi-asserted-by":"publisher","award":["SZS2024016"],"award-info":[{"award-number":["SZS2024016"]}],"id":[{"id":"10.13039\/100018916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018916","name":"Suzhou Municipal Health Commission","doi-asserted-by":"publisher","award":["DZXYJ202413"],"award-info":[{"award-number":["DZXYJ202413"]}],"id":[{"id":"10.13039\/100018916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010854","name":"Jiangsu Provincial Commission of Health and Family Planning","doi-asserted-by":"publisher","award":["Z2023074"],"award-info":[{"award-number":["Z2023074"]}],"id":[{"id":"10.13039\/501100010854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009159","name":"Lianyungang City Science and Technology Bureau","doi-asserted-by":"publisher","award":["QN202310"],"award-info":[{"award-number":["QN202310"]}],"id":[{"id":"10.13039\/501100009159","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017544","name":"Lianyungang City Health and Family Planning Commission","doi-asserted-by":"publisher","award":["L202312"],"award-info":[{"award-number":["L202312"]}],"id":[{"id":"10.13039\/501100017544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.schres.2026.07.016","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:06:40Z","timestamp":1784369200000},"page":"147-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inflammatory markers and niacin skin flush response in men with chronic schizophrenia"],"prefix":"10.1016","volume":"296","author":[{"given":"Man","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linya","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2026.07.016_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.771144","article-title":"Inflammation and JNK\u2019s role in niacin-GPR109A diminished flushed effect in microglial and neuronal cells with relevance to schizophrenia","volume":"12","author":"Ansarey","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.016_bb0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.schres.2025.04.003","article-title":"Developing a risk assessment model for treatment-resistant schizophrenia: the role of niacin receptor GPR109A and prostaglandin receptors DP(1), EP(2), and EP(4) in the niacin-induced flushing pathway","volume":"280","author":"Chiu","year":"2025","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2026.07.016_bb0015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/FJC.0000000000000181","article-title":"TRPV1 channels are involved in niacin-induced cutaneous vasodilation in mice","volume":"65","author":"Clifton","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.schres.2026.07.016_bb0020","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neubiorev.2021.03.004","article-title":"Impaired regulatory T cell control of astroglial overdrive and microglial pruning in schizophrenia","volume":"125","author":"Corsi-Zuelli","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.schres.2026.07.016_bb0025","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/147323000203000313","article-title":"Serum interleukin 1 alpha and interleukin 2 levels in patients with schizophrenia","volume":"30","author":"Ebrin\u00e7","year":"2002","journal-title":"J. Int. Med. Res."},{"issue":"1","key":"10.1016\/j.schres.2026.07.016_bb0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mcna.2022.05.005","article-title":"Schizophrenia: one name, many different manifestations","volume":"107","author":"Faden","year":"2023","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.schres.2026.07.016_bb0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bbi.2018.11.315","article-title":"Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis","volume":"76","author":"Goldsmith","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.schres.2026.07.016_bb0040","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.pnpbp.2008.06.004","article-title":"Serum levels of brain-derived neurotrophic factor in schizophrenia on a hypocaloric diet","volume":"32","author":"Guimar\u00e3es","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2026.07.016_bb0045","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2215-0366(23)00025-1","article-title":"Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis","volume":"10","author":"Halstead","year":"2023","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2026.07.016_bb0050","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"10","key":"10.1016\/j.schres.2026.07.016_bb0055","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","article-title":"Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study","volume":"71","author":"Khandaker","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2026.07.016_bb0060","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1248\/bpb.31.1938","article-title":"Anti-inflammatory and immunomodulatory properties of 2-amino-3H-phenoxazin-3-one","volume":"31","author":"Kohno","year":"2008","journal-title":"Biol. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.schres.2026.07.016_bb0065","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/sj.clpt.6100180","article-title":"Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1","volume":"81","author":"Lai","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.schres.2026.07.016_bb0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.schres.2017.06.007","article-title":"State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - an optical reflection spectroscopy study","volume":"192","author":"Langbein","year":"2018","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2026.07.016_bb0075","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1189\/jlb.0307153","article-title":"Plasticity of dendritic cell function in response to prostaglandin E2 (PGE2) and interferon-gamma (IFN-gamma)","volume":"83","author":"Lehner","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.schres.2026.07.016_bb0080","doi-asserted-by":"crossref","first-page":"571","DOI":"10.15252\/emmm.201606987","article-title":"Niacin ameliorates ulcerative colitis via prostaglandin D(2)-mediated D prostanoid receptor 1 activation","volume":"9","author":"Li","year":"2017","journal-title":"EMBO Mol. Med."},{"issue":"2\u20133","key":"10.1016\/j.schres.2026.07.016_bb0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.psychres.2006.10.002","article-title":"Absent response to niacin skin patch is specific to schizophrenia and independent of smoking","volume":"152","author":"Liu","year":"2007","journal-title":"Psychiatry Res."},{"issue":"7","key":"10.1016\/j.schres.2026.07.016_bb0090","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1038\/s41380-020-00914-0","article-title":"Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis","volume":"26","author":"Lizano","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.07.016_bb0095","article-title":"Exploring the role of TNF-\u03b1, TGF-\u03b2, and IL-6 serum levels in categorical and noncategorical models of mood and psychosis","volume":"14","author":"Maja","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.schres.2026.07.016_bb0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.plefa.2017.06.014","article-title":"The niacin response biomarker as a schizophrenia endophenotype: a status update","volume":"136","author":"Messamore","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"7","key":"10.1016\/j.schres.2026.07.016_bb0105","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.016_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2021.105200","article-title":"Immune-inflammatory markers and psychosis risk: a systematic review and meta-analysis","volume":"127","author":"Misiak","year":"2021","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.schres.2026.07.016_bb0115","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0306-4522(02)00123-9","article-title":"A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning","volume":"112","author":"Molteni","year":"2002","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.schres.2026.07.016_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10090633","article-title":"The endogenous opioid system in schizophrenia and treatment resistant schizophrenia: increased plasma endomorphin 2, and \u03ba and \u03bc opioid receptors are associated with interleukin-6","volume":"10","author":"Moustafa","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.schres.2026.07.016_bb0125","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jpsychires.2020.09.003","article-title":"Sex differences in association between clinical correlates and cognitive impairment in patients with chronic schizophrenia","volume":"131","author":"Mu","year":"2020","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.schres.2026.07.016_bb0130","first-page":"14","article-title":"Niacin skin flush test: a research tool for studying schizophrenia","volume":"22","author":"Nadalin","year":"2010","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.schres.2026.07.016_bb0135","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbi.2021.07.009","article-title":"Associations of immunological proteins\/traits with schizophrenia, major depression and bipolar disorder: a bi-directional two-sample Mendelian randomization study","volume":"97","author":"Perry","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.schres.2026.07.016_bb0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0079-6123(07)63020-9","article-title":"Pro-inflammatory cytokines and their effects in the dentate gyrus","volume":"163","author":"Pickering","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.schres.2026.07.016_bb0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pneurobio.2013.02.001","article-title":"Current status of chemokines in the adult CNS","volume":"104","author":"R\u00e9aux-Le Goazigo","year":"2013","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.schres.2026.07.016_bb0150","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s12035-019-01737-z","article-title":"The role of aberrations in the immune-inflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia","volume":"57","author":"Roomruangwong","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.schres.2026.07.016_bb0155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ajp.2015.07.016","article-title":"Contribution of sex hormones to gender differences in schizophrenia: a review","volume":"18","author":"Silva","year":"2015","journal-title":"Asian J. Psychiatr."},{"issue":"5","key":"10.1016\/j.schres.2026.07.016_bb0160","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jpsychires.2004.01.007","article-title":"The influence of age and gender on niacin skin test results - implications for the use as a biochemical marker in schizophrenia","volume":"38","author":"Smesny","year":"2004","journal-title":"J. Psychiatr. Res."},{"issue":"12","key":"10.1016\/j.schres.2026.07.016_bb0165","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1038\/s41380-023-02138-4","article-title":"Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019","volume":"28","author":"Solmi","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.016_bb0170","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jpsychires.2018.08.017","article-title":"Second generation atypical antipsychotics olanzapine and aripiprazole reduce expression and secretion of inflammatory cytokines in human immune cells","volume":"105","author":"Stapel","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2026.07.016_bb0175","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.psyneuen.2013.12.005","article-title":"Increased serum interleukin-6 levels in early stages of psychosis: associations with at-risk mental states and the severity of psychotic symptoms","volume":"41","author":"Stojanovic","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2026.07.016_bb0180","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jpsychires.2025.04.025","article-title":"Niacin skin flushing response in patients with schizophrenia: associations with the efficacy of modified electroconvulsive therapy and clinical symptoms","volume":"186","author":"Sui","year":"2025","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.schres.2026.07.016_bb0185","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/schbul\/sbx150","article-title":"Identification of the niacin-blunted subgroup of schizophrenia patients from mood disorders and healthy individuals in Chinese population","volume":"44","author":"Sun","year":"2018","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.schres.2026.07.016_bb0190","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00406-023-01677-9","article-title":"The relationship between inflammatory markers, clinical characteristics, and cognitive performance in drug-na\u00efve patients with schizophrenia","volume":"274","author":"Sun","year":"2024","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2026.07.016_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(02)00281-5","article-title":"Increased phospholipase A2 activity in schizophrenia with absent response to niacin","volume":"61","author":"Tavares","year":"2003","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.schres.2026.07.016_bb0200","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.schres.2026.07.016_bb0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/7854_2018_88","article-title":"Cytokines, oxidative stress and cellular markers of inflammation in schizophrenia","volume":"44","author":"Upthegrove","year":"2020","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"5","key":"10.1016\/j.schres.2026.07.016_bb0210","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jamapsychiatry.2022.0407","article-title":"Inflammation and brain structure in schizophrenia and other neuropsychiatric disorders: a Mendelian randomization study","volume":"79","author":"Williams","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2026.07.016_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146463","article-title":"Association of peripheral cytokine levels with cerebral structural abnormalities in schizophrenia","volume":"1724","author":"Wu","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2026.07.016_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103239","article-title":"Dysregulation of phospholipase and cyclooxygenase expression is involved in schizophrenia","volume":"64","author":"Yang","year":"2021","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.schres.2026.07.016_bb0225","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1399-0039.2012.01886.x","article-title":"Interleukin-6 promoter polymorphism and plasma levels in patients with schizophrenia","volume":"80","author":"Zakharyan","year":"2012","journal-title":"Tissue Antigens"},{"issue":"5","key":"10.1016\/j.schres.2026.07.016_bb0230","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22m14731","article-title":"Association of attenuated niacin response with inflammatory imbalance and prediction of conversion to psychosis from clinical high-risk stage","volume":"84","author":"Zhang","year":"2023","journal-title":"J. Clin. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:17:57Z","timestamp":1788779877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426002252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":46,"alternative-id":["S0920996426002252"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.07.016","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory markers and niacin skin flush response in men with chronic schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}